Taiwan FDA registration 147ef6301eb00a926b07b2244496f056

"Daishoulin" tumor multi-victory antigen radioimmunoassay reagent

TW: "岱首林" 腫瘤多胜呔抗原放射免疫分析試劑
Taiwan flagTaiwan·Risk Class 2·DIASORIN INC.;;DIASORIN S.P.A.·Registered Apr 04, 2006 – Apr 04, 2011Cancelled
Registration details
Analysis ID
147ef6301eb00a926b07b2244496f056
Customs Code
DHA00601629209
Company information
Manufacturer Country
Italy;;United States
Authorized Representative
TAIWAN LIFE SUPPORT SYSTEMS INC.
Product details
Intended Use
It is used to quantitatively detect soluble fragments of keratin 8, 18 and 19 in serum and other body fluids.
Product Type (Level 1)
C Immunology and microbiology
Product Type (Level 2)
C.6010 腫瘤相關抗原免疫試驗系統
Import Information
Input;; Consent letter must be attached to the import (consent from the Atomic Energy Commission must be obtained for each import)
Dates and status
Registration Date
Apr 04, 2006
Expiry Date
Apr 04, 2011
Cancellation Date
Nov 27, 2012
Cancellation information
Status
Logged out
Reason
許可證已逾有效期
About this record

Access comprehensive regulatory information for "Daishoulin" tumor multi-victory antigen radioimmunoassay reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 147ef6301eb00a926b07b2244496f056 and manufactured by DIASORIN INC.;;DIASORIN S.P.A.. The authorized representative in Taiwan is TAIWAN LIFE SUPPORT SYSTEMS INC..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices